Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Cohort Analysis
89%
Phototherapy
63%
Adolescent
61%
Bilirubin
55%
Insulin Dependent Diabetes Mellitus
52%
Neonatal Hyperbilirubinemia
50%
Neonates
48%
Symptom
45%
Pediatrics
42%
Malignant Neoplasm
37%
Diseases
36%
Neonatal Infant
29%
COVID-19
28%
Pediatrics Patient
25%
Prematurity
23%
Severe Acute Respiratory Syndrome Coronavirus 2
22%
Neonatal Intensive Care Unit
22%
Hyperbilirubinemia
21%
Neoplasm
21%
Kernicterus
20%
Randomized Controlled Trial
19%
Gestational Age
19%
Prevalence
19%
Diabetes
18%
Surfactant
17%
Diagnostic Error
17%
Infection
16%
Pediatric Oncology
16%
Pediatric Hematology
16%
Spastic Diplegia
15%
Diagnosis
15%
Pregnancy
15%
Gut Microbiota
14%
Hemoglobin A1c
14%
Childhood Cancer
14%
Systematic Review
14%
Respiratory Disease
14%
Thromboembolism
14%
Childbirth
14%
Continuous Positive Airway Pressure
13%
Gestational Diabetes
13%
Randomized Clinical Trial
13%
Lung Dysplasia
13%
Respiratory Distress Syndrome
12%
Spectrum Disorder
11%
Clinical Trial
11%
Cross Sectional Study
11%
Neonatal Jaundice
11%
Diurnal Enuresis
10%
Retrospective Cohort Study
10%
Arthritis
10%
Drug Therapy
10%
Kidney Function
10%
Gastric Suction
10%
Triage
10%
Cumulative Incidence
10%
Meta-Analysis
9%
Artificial Respiration
9%
Urine Incontinence
9%
Urinary Tract Infection
9%
Health Care Utilization
9%
Analgesia
9%
Methotrexate
9%
Urinary System
9%
Case-Control Study
9%
Diagnostic Delay
9%
Transcutaneous Electrical Nerve Stimulation
9%
Precocious Puberty
9%
Idiopathic Thrombocytopenic Purpura
9%
Household
9%
Nonalcoholic Fatty Liver
9%
Cohort Effect
9%
Pediatric Cancer
9%
Blood Group ABO Incompatibility
9%
End of Life Care
9%
Pain Assessment
9%
Adolescence
9%
Antibiotics
8%
Surgery
8%
Nerve Fiber
8%
Musculoskeletal Diagnosis
8%
Placebo
8%
Sequela
8%
Body Mass Index
7%
Central Nervous System Tumor
7%
Supplementation
7%
Adverse Event
7%
Bacteremia
7%
Cancer Registry
7%
Bladder
7%
Allele
6%
Urination
6%
Drug Megadose
6%
Protocol Compliance
6%
Bloodstream Infection
6%
Prognostic Factor
6%
Glycemic Control
6%
Platelet
6%
Treatment Response
6%
Keyphrases
Acute Lymphoblastic Leukemia
21%
Adolescents with Type 1 Diabetes
13%
Denmark
13%
Myopericarditis
9%
Bladder Pain Syndrome
9%
High-dose Methotrexate (HD-MTX)
9%
Phototherapy
9%
Children with Cancer
8%
Parental Experience
7%
Type I Diabetes
7%
Type 1 Diabetes Mellitus (T1DM)
7%
Acute Lymphoblastic Leukemia Survivors
7%
L-asparaginase
7%
Total Bilirubin
6%
Systemic Juvenile Idiopathic Arthritis (sJIA)
5%
Cerebral Palsy
5%
Glycemic Control
5%
LED Phototherapy
5%
Delayed Elimination
5%
Epidemiological Research
5%
Hemoglobin
5%
Pediatric Hematology
5%
Pediatric Oncology
5%
Arthropathy
5%
Blue LED
5%